Biogen to acquire Nightstar Therapeutics for $800M

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Monday, Biogen announced it would acquire Nightstar Therapeutics in the $800M worth cash-deal, amid company's intention to expand its footprint in the gene therapy market.
Back to articles

Actual Topics

Mon, 04 Mar 2019 10:33:20 GMT

SpaceX launches rocket with unmanned US capsule

Elon Musk's SpaceX has launched an unmanned US capsule this weekend, called Crew Dragon, with a successful separation from the rocket eleven minutes later to start a journey to its space station.

Mon, 04 Mar 2019 09:34:04 GMT

DataStax gears up for IPO this year

The data management platform, DataStax, is preparing to launch an initial public offering scheduled for the current year that could potentially value the firm at over $1.0B, sources with a knowledge reported.

Subscribe to "Fundamental Analysis" feed

Subscribe
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
Pre viac informácií o Dukascopy Bank CFD / Forex obchodných platformách a ostatných záležitostiach
nás prosím kontaktujte alebo požiadajte o hovor od nás.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.